What is an Atherogenic Index of Plasma Blood Test?

AIP: A Log-Ratio Snapshot of Lipid Particle Quality

The Atherogenic Index of Plasma (AIP) is a calculated snapshot of your blood's lipid mix. It combines two routine lipid values—triglycerides and HDL cholesterol—to summarize how fats made in the liver and absorbed from the gut travel in the bloodstream inside carrier particles (lipoproteins). AIP isn't a substance you can see under a microscope; it's a single number distilled from these circulating lipids to represent the overall "tone" of your plasma.

AIP matters because it reflects the balance between triglyceride‑rich particles that deliver fat outward and can leave cholesterol behind (VLDL and remnants) and HDL particles that help carry cholesterol back to the liver for disposal (reverse cholesterol transport). That balance influences the formation of small, dense LDL particles and remnant lipoproteins—forms more apt to slip into artery walls and fuel plaque buildup (atherogenesis). In short, AIP captures the atherogenic character of your plasma and serves as a practical proxy for lipoprotein particle quality and behavior (small, dense LDL; remnant lipoproteins), condensing complex lipid biology into one clinically useful index.

Why "Stickiness" of Blood Lipids Matters

The Atherogenic Index of Plasma (AIP) distills how "sticky" your blood lipids are by comparing triglycerides to HDL cholesterol. It reflects the balance between particles that deposit cholesterol in artery walls and those that carry it away, linking lipid metabolism with vascular health, insulin signaling, and liver fat handling.

Reading an AIP Value

In general, lower values are better. Values below about 0.11 are associated with lower cardiovascular risk, 0.11–0.24 with average risk, and above 0.24 with higher risk. When AIP is low or even negative, triglycerides are modest and HDL is effective, favoring larger, less harmful LDL particles and efficient reverse cholesterol transport. This pattern aligns with better insulin sensitivity and supple arteries. People usually feel well; there are no specific symptoms. Men tend to have slightly higher AIP than women, and it often rises after menopause. In children and teens, low AIP tracks with healthier weight and metabolic profiles.

When AIP is high, the blood carries more triglyceride-rich remnants and small, dense LDL—particles that penetrate the artery wall, inflame the endothelium, and promote plaque. It often travels with insulin resistance, abdominal obesity, higher blood pressure, and fatty liver. Most people feel nothing, though very high triglycerides can precede pancreatitis. During pregnancy, triglycerides naturally rise, so AIP may increase; markedly elevated values can signal heightened cardiometabolic stress.

Low values usually reflect low triglycerides and/or higher HDL, indicating efficient fat clearance (lipoprotein lipase activity), effective reverse cholesterol transport, and larger, less harmful LDL particles. Systemically this aligns with better metabolic flexibility and vascular resilience. Lower AIP is more typical in younger people and premenopausal women.

High values usually reflect high triglycerides relative to HDL, pointing to insulin resistance, increased hepatic VLDL output, impaired HDL maturation, and a shift toward small, dense LDL. System effects include higher plaque propensity, endothelial dysfunction, and association with fatty liver. Higher AIP is more common in men, with aging, and after menopause; it also rises in normal pregnancy, especially late gestation.

What Can Move an AIP Number

AIP is sensitive to fasting status, recent alcohol, acute illness, and thyroid or kidney disorders. Estrogens, steroids, beta‑blockers, retinoids, and some antivirals can shift values. Pregnancy physiologically elevates AIP. Consistent unit conventions help when comparing results across labs or time.

What to Pair With AIP

AIP integrates the liver's VLDL output, HDL function, and glucose–insulin dynamics. It complements LDL and non-HDL cholesterol to estimate lifetime risk for atherosclerosis, type 2 diabetes progression, fatty liver, heart attack, and stroke. Lower AIP suggests a more resilient cardiometabolic system.

What AIP Adds Beyond a Standard Lipid Panel

Being in range suggests balanced lipoprotein metabolism, with controlled VLDL production and adequate HDL-mediated cholesterol recycling. This pattern supports stable glucose–lipid signaling and lower atherogenic burden; consensus generally places "within reference ranges" toward the lower end of the usual range.